![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Wockhardt Limited Ankleshwar In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Ranitidine hydrochloride, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2000-168 - Rev 01
This Chemical Type CEP, issued on September 27, 2005, remains in force until November 19, 2008, ensuring its reliability within the pharmaceutical industry.
Substance Number 946 associated with this CEP further emphasizes